Pegloticase and Methotrexate Co-administered in Participants With Uncontrolled Gout Who Previously Failed Pegloticase Monotherapy
Clinical trial NCT04772313 · COMPLETED
Trial details
- NCT number
- NCT04772313
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-08
- Primary completion
- 2022-08-23
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.